vs
Side-by-side financial comparison of Good Times Restaurants Inc. (GTIM) and Sight Sciences, Inc. (SGHT). Click either name above to swap in a different company.
Good Times Restaurants Inc. is the larger business by last-quarter revenue ($32.7M vs $20.4M, roughly 1.6× Sight Sciences, Inc.). Good Times Restaurants Inc. runs the higher net margin — 0.6% vs -20.4%, a 21.0% gap on every dollar of revenue. On growth, Sight Sciences, Inc. posted the faster year-over-year revenue change (6.9% vs -10.0%). Good Times Restaurants Inc. produced more free cash flow last quarter ($1.2M vs $-2.0M). Over the past eight quarters, Sight Sciences, Inc.'s revenue compounded faster (2.9% CAGR vs -0.7%).
Good Times is a Golden, Colorado–based fast-food restaurant specializing in premium burgers and frozen custard. As of July 2023, the chain operates 31 locations, down from 38 in 2015.
Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.
GTIM vs SGHT — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $32.7M | $20.4M |
| Net Profit | $181.0K | $-4.2M |
| Gross Margin | — | 87.3% |
| Operating Margin | 0.9% | -18.0% |
| Net Margin | 0.6% | -20.4% |
| Revenue YoY | -10.0% | 6.9% |
| Net Profit YoY | 10.4% | 64.9% |
| EPS (diluted) | $0.02 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $32.7M | $20.4M | ||
| Q3 25 | $37.0M | $19.9M | ||
| Q2 25 | $34.3M | $19.6M | ||
| Q1 25 | — | $17.5M | ||
| Q4 24 | $36.3M | $19.1M | ||
| Q3 24 | $35.8M | $20.2M | ||
| Q2 24 | $38.0M | $21.4M | ||
| Q1 24 | $35.4M | $19.3M |
| Q4 25 | $181.0K | $-4.2M | ||
| Q3 25 | $1.5M | $-8.2M | ||
| Q2 25 | $-624.0K | $-11.9M | ||
| Q1 25 | — | $-14.2M | ||
| Q4 24 | $164.0K | $-11.8M | ||
| Q3 24 | $230.0K | $-11.1M | ||
| Q2 24 | $1.3M | $-12.3M | ||
| Q1 24 | $618.0K | $-16.3M |
| Q4 25 | — | 87.3% | ||
| Q3 25 | — | 86.4% | ||
| Q2 25 | — | 84.8% | ||
| Q1 25 | — | 86.2% | ||
| Q4 24 | — | 86.8% | ||
| Q3 24 | — | 83.9% | ||
| Q2 24 | — | 85.8% | ||
| Q1 24 | — | 85.5% |
| Q4 25 | 0.9% | -18.0% | ||
| Q3 25 | 3.3% | -39.7% | ||
| Q2 25 | -1.5% | -59.6% | ||
| Q1 25 | — | -79.2% | ||
| Q4 24 | 0.2% | -62.5% | ||
| Q3 24 | -0.3% | -55.7% | ||
| Q2 24 | 3.2% | -59.2% | ||
| Q1 24 | 1.8% | -76.4% |
| Q4 25 | 0.6% | -20.4% | ||
| Q3 25 | 4.0% | -41.0% | ||
| Q2 25 | -1.8% | -61.0% | ||
| Q1 25 | — | -80.8% | ||
| Q4 24 | 0.5% | -62.1% | ||
| Q3 24 | 0.6% | -54.9% | ||
| Q2 24 | 3.5% | -57.7% | ||
| Q1 24 | 1.7% | -84.4% |
| Q4 25 | $0.02 | $-0.07 | ||
| Q3 25 | $0.14 | $-0.16 | ||
| Q2 25 | $-0.06 | $-0.23 | ||
| Q1 25 | — | $-0.28 | ||
| Q4 24 | $0.02 | $-0.23 | ||
| Q3 24 | $0.01 | $-0.22 | ||
| Q2 24 | $0.12 | $-0.25 | ||
| Q1 24 | $0.06 | $-0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $92.0M |
| Total DebtLower is stronger | — | $42.4M |
| Stockholders' EquityBook value | $33.2M | $63.9M |
| Total Assets | $82.5M | $115.3M |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $92.0M | ||
| Q3 25 | — | $92.4M | ||
| Q2 25 | $2.7M | $101.5M | ||
| Q1 25 | — | $108.8M | ||
| Q4 24 | $3.0M | $120.4M | ||
| Q3 24 | $3.9M | $118.6M | ||
| Q2 24 | — | $118.2M | ||
| Q1 24 | $4.0M | $127.3M |
| Q4 25 | — | $42.4M | ||
| Q3 25 | — | $42.4M | ||
| Q2 25 | — | $42.4M | ||
| Q1 25 | — | $42.4M | ||
| Q4 24 | — | $40.0M | ||
| Q3 24 | — | $37.1M | ||
| Q2 24 | — | $35.0M | ||
| Q1 24 | — | $35.0M |
| Q4 25 | $33.2M | $63.9M | ||
| Q3 25 | $33.1M | $64.3M | ||
| Q2 25 | $31.6M | $70.0M | ||
| Q1 25 | — | $77.6M | ||
| Q4 24 | $32.4M | $87.5M | ||
| Q3 24 | $32.4M | $95.0M | ||
| Q2 24 | $32.3M | $101.6M | ||
| Q1 24 | $31.6M | $109.2M |
| Q4 25 | $82.5M | $115.3M | ||
| Q3 25 | $85.8M | $116.3M | ||
| Q2 25 | $86.9M | $122.0M | ||
| Q1 25 | — | $129.7M | ||
| Q4 24 | $89.5M | $142.8M | ||
| Q3 24 | $87.1M | $143.6M | ||
| Q2 24 | $90.1M | $149.7M | ||
| Q1 24 | $89.0M | $155.6M |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.66× | ||
| Q2 25 | — | 0.61× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | 0.46× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 0.32× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.4M | $-1.8M |
| Free Cash FlowOCF − Capex | $1.2M | $-2.0M |
| FCF MarginFCF / Revenue | 3.8% | -9.7% |
| Capex IntensityCapex / Revenue | 0.6% | 0.8% |
| Cash ConversionOCF / Net Profit | 7.85× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-72.0K | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4M | $-1.8M | ||
| Q3 25 | $1.3M | $-8.7M | ||
| Q2 25 | $714.0K | $-7.5M | ||
| Q1 25 | — | $-11.6M | ||
| Q4 24 | $-518.0K | $-3.5M | ||
| Q3 24 | $394.0K | $362.0K | ||
| Q2 24 | $3.2M | $-9.5M | ||
| Q1 24 | $1.8M | $-9.8M |
| Q4 25 | $1.2M | $-2.0M | ||
| Q3 25 | $735.0K | $-8.9M | ||
| Q2 25 | $-105.0K | $-7.8M | ||
| Q1 25 | — | — | ||
| Q4 24 | $-1.9M | $-3.6M | ||
| Q3 24 | $-466.0K | $311.0K | ||
| Q2 24 | $2.0M | $-9.5M | ||
| Q1 24 | $1.2M | $-9.9M |
| Q4 25 | 3.8% | -9.7% | ||
| Q3 25 | 2.0% | -44.7% | ||
| Q2 25 | -0.3% | -39.6% | ||
| Q1 25 | — | — | ||
| Q4 24 | -5.3% | -18.9% | ||
| Q3 24 | -1.3% | 1.5% | ||
| Q2 24 | 5.3% | -44.7% | ||
| Q1 24 | 3.2% | -51.4% |
| Q4 25 | 0.6% | 0.8% | ||
| Q3 25 | 1.4% | 0.9% | ||
| Q2 25 | 2.4% | 1.1% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | 3.9% | 0.7% | ||
| Q3 24 | 2.4% | 0.3% | ||
| Q2 24 | 3.2% | 0.4% | ||
| Q1 24 | 1.7% | 0.6% |
| Q4 25 | 7.85× | — | ||
| Q3 25 | 0.85× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -3.16× | — | ||
| Q3 24 | 1.71× | — | ||
| Q2 24 | 2.44× | — | ||
| Q1 24 | 2.86× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GTIM
Segment breakdown not available.
SGHT
| Surgical Glaucoma | $19.7M | 96% |
| Other | $724.0K | 4% |
